Eye & EarICD-10: H40Affects more than 3 million Americans, with half unaware they have it

Glaucoma

Also known as: Open-Angle Glaucoma, Angle-Closure Glaucoma

Glaucoma is a group of eye diseases that damage the optic nerve, usually due to abnormally high intraocular pressure. It is a leading cause of irreversible blindness worldwide, and vision loss cannot be recovered. Early detection through regular eye exams is critical because glaucoma often has no symptoms until significant vision loss has occurred.

Last updated November 10, 2026

Understanding Glaucoma

Glaucoma is a family of diseases in which the optic nerve, the cable that carries everything the retina sees to the brain, is slowly destroyed, most often because the pressure inside the eye is higher than that particular nerve can tolerate. Primary open-angle glaucoma accounts for roughly 9 in 10 cases in the United States; angle-closure glaucoma is less common but far more dangerous because it can strike within hours. About 3 million Americans and an estimated 80 million people worldwide have glaucoma, and roughly half of those in the United States do not know it. Prevalence climbs from about 1 in 50 adults over 40 to roughly 1 in 10 over 80. Black Americans develop open-angle glaucoma three to four times as often as white Americans and about a decade earlier; people of East Asian ancestry, women and the far-sighted are at higher risk of angle closure; and having a parent or sibling with glaucoma raises your own risk severalfold.

The front of the eye is constantly filled with a clear fluid called aqueous humor, made behind the iris and drained through a spongy filter, the trabecular meshwork, in the angle where the iris meets the cornea. In open-angle glaucoma that filter gradually resists outflow, so pressure creeps up, typically above the normal range of 10 to 21 mmHg, and the pressure strains the million or so nerve fibers where they exit the eye. Fibers serving peripheral vision die first, and the brain quietly fills in the gaps, which is why visual field defects are usually only measurable after a quarter or more of the retinal ganglion cells are already gone. About a third of American patients have optic nerve damage with pressures that never leave the normal range, so-called normal-tension glaucoma. In angle closure, the iris itself bows forward and blocks the drain; in an acute attack, pressure can reach 40 to 80 mmHg and the nerve can be permanently damaged within a day.

Lowering eye pressure is the only treatment proven to slow glaucoma, and the trials behind it are large. In the Ocular Hypertension Treatment Study, 1,636 people with high pressure but no damage were randomized to drops or observation; a roughly 20 percent pressure reduction cut the 5-year rate of developing glaucoma from 9.5 to 4.4 percent. In the Early Manifest Glaucoma Trial, treatment reduced 6-year progression from 62 to 45 percent, and each 1 mmHg of lowering cut risk by about 10 percent. Prostaglandin drops such as latanoprost lower pressure 25 to 33 percent with one drop at night. The 2019 LiGHT trial changed the first step: 718 newly diagnosed patients were randomized to selective laser trabeculoplasty (SLT) or drops, and at 3 years 74 percent of the laser group were at target pressure with no drops at all. At 6 years about 70 percent were still drop-free and fewer had progressed. NICE now recommends SLT first for newly diagnosed open-angle glaucoma, and the American Academy of Ophthalmology lists it as an acceptable initial treatment. Acute angle closure is treated with a laser iridotomy, a tiny hole in the iris that reopens the drain.

No supplement lowers eye pressure enough to replace drops or laser, and anyone who tells you otherwise is guessing with your eyesight. The strongest pressure-lowering drops cut pressure by 6 to 8 mmHg; the best supplement result is a 3-month omega-3 trial in 105 healthy adults that lowered pressure by about 1 mmHg, and it has not been repeated in glaucoma patients. Where natural compounds may eventually earn a place is in protecting the nerve itself. Nicotinamide, a form of vitamin B3, improved the electrical function of retinal ganglion cells in a 57-person placebo-controlled crossover trial at 1.5 to 3 g a day, and large multi-year trials are under way to see whether that translates into preserved vision. Citicoline and ginkgo have small, mixed studies in normal-tension glaucoma. Cannabis lowers pressure for 3 to 4 hours, which would mean dosing six to eight times a day, and the American Academy of Ophthalmology advises against it. Bilberry, lutein, vitamin C and magnesium have no meaningful glaucoma data. Caffeine briefly raises pressure by 1 to 2 mmHg, and in the UK Biobank, people with high genetic risk who drank the most caffeine had almost four times the odds of glaucoma.

The most common mistake is stopping the drops because nothing feels wrong. Open-angle glaucoma is painless, the vision you have lost does not announce itself, and the drops sting, redden the eye or cost money, so by one year roughly half of patients are no longer using them as prescribed. Each missed stretch is pressure the nerve absorbs with no way to recover. If drops are a problem, say so: SLT, combination bottles, preservative-free formulations and pressing on the tear duct for a minute after each drop are all options. The second mistake is assuming an air-puff pressure check at a glasses appointment rules glaucoma out. Pressure alone misses the third of patients with normal-tension disease; a real glaucoma exam includes a dilated look at the optic nerve, gonioscopy to inspect the drainage angle and, when anything looks suspicious, a visual field test and OCT scan. The third is treating sudden eye pain with halos, headache and nausea as a migraine or stomach bug; that combination is an acute angle-closure attack until proven otherwise and needs an emergency department the same day.

At a Glance

Common symptoms
Gradual loss of peripheral (side) vision, often in both eyes, Tunnel vision in advanced stages, Severe eye pain and headache (acute angle-closure glaucoma)
Main treatments
Prescription eye drops to reduce intraocular pressure, Oral carbonic anhydrase inhibitors for acute pressure reduction, Laser trabeculoplasty to improve drainage
Category
Eye & Ear · Affects more than 3 million Americans, with half unaware they have it
See a doctor if
You experience sudden severe eye pain, headache, or blurred vision

Symptoms

Gradual loss of peripheral (side) vision, often in both eyes
Tunnel vision in advanced stages
Severe eye pain and headache (acute angle-closure glaucoma)
Nausea and vomiting accompanying eye pain
Sudden blurred vision
Halos around lights
Eye redness

Causes

  • Elevated intraocular pressure from impaired aqueous humor drainage
  • Damage to the optic nerve from pressure or reduced blood flow
  • Open-angle: slow clogging of drainage canals over time
  • Angle-closure: sudden blockage of drainage angle by the iris

Risk Factors

  • Age over 60
  • African, Hispanic, or Asian ancestry
  • Family history of glaucoma
  • Elevated intraocular pressure
  • Extreme nearsightedness or farsightedness
  • Long-term corticosteroid use

Diagnosis

  • Tonometry to measure intraocular pressure
  • Ophthalmoscopy to examine the optic nerve
  • Visual field testing (perimetry) to detect peripheral vision loss
  • Optical coherence tomography (OCT) to measure nerve fiber thickness
  • Gonioscopy to examine the drainage angle

Treatment

  • Prescription eye drops to reduce intraocular pressure
  • Oral carbonic anhydrase inhibitors for acute pressure reduction
  • Laser trabeculoplasty to improve drainage
  • Minimally invasive glaucoma surgery (MIGS)
  • Traditional surgery (trabeculectomy or drainage implant) for advanced cases

Natural remedies for glaucoma: what the evidence says

Ranked by the strength of human evidence for glaucoma specifically. These sit alongside medical care, not in place of it.

  1. Nicotinamide (vitamin B3)

    Preliminary evidence

    Retinal ganglion cells in glaucoma appear to run short of NAD+, and in glaucoma-prone mice nicotinamide in the diet prevented most nerve damage. In a 2020 placebo-controlled crossover trial, 57 people with treated glaucoma took 1.5 g a day for 6 weeks then 3 g a day for 6 weeks, and electroretinography showed a measurable improvement in inner retinal function, with a small gain in visual field scores. A 2022 trial of 32 patients combining nicotinamide with pyruvate for 2 months found more visual field test points improving than on placebo. These are short studies of function, not proof that vision is preserved; multi-year trials in Sweden, Australia and the United States are in progress.

    Studied dose
    There is no established dose for routine use. The trials used 1.5 to 3 g of nicotinamide (not nicotinic acid, which causes flushing) a day in divided doses, and the 2025 American Glaucoma Society and American Academy of Ophthalmology position statement advises against 3 g a day or more outside a monitored clinical trial. Any use below that needs your ophthalmologist's agreement and periodic liver function tests, with pressure treated as usual.
    Cautions
    Gram doses have caused drug-induced liver injury, which is why the 2025 AGS/AAO statement calls for periodic liver function testing at any dose and advises against nicotinamide altogether in anyone with current or past liver disease. It can also raise blood glucose, so people with diabetes or kidney disease need monitoring. It does not lower eye pressure and is not a substitute for drops or laser. Separate from carbamazepine and primidone, whose levels it can raise.
  2. Citicoline

    Preliminary evidence

    Citicoline supports the membranes and energy metabolism of nerve cells. In small Italian trials of 30 to 60 glaucoma patients, 500 to 1,600 mg a day by mouth or injection for 60 days improved pattern electroretinogram and visual evoked potential readings, which partly reversed after stopping. In an 80-patient 3-year trial, citicoline eye drops added to pressure-lowering drops roughly halved the rate of visual field loss. No large trial has measured whether people keep more usable vision over the long term.

    Studied dose
    500 to 1,000 mg citicoline by mouth daily, in cycles of 2 to 4 months as used in trials; citicoline eye drops are sold in Europe but not approved in the United States.
    Cautions
    Generally well tolerated; occasional headache, insomnia or stomach upset. Avoid combining with levodopa without advice because it can increase dopamine effects. It does not lower eye pressure.
  3. Ginkgo Biloba

    Preliminary evidence

    Ginkgo improves blood flow in small vessels, which is why it has been tested in normal-tension glaucoma, where poor optic nerve perfusion is suspected. A 2003 crossover trial in 27 patients found 40 mg three times daily for 4 weeks improved visual field indices, but a 2014 trial with the same design in 35 Chinese patients found no change. A Korean retrospective study of 42 patients followed for about 12 years reported slower field loss while taking ginkgo, which cannot separate the herb from the kind of patient who takes it. It has no effect on eye pressure.

    Studied dose
    40 mg standardized extract (EGb 761, 24 percent flavone glycosides) three times daily, or 120 mg once daily, for at least 4 weeks.
    Cautions
    Increases bleeding risk with warfarin, aspirin, clopidogrel and NSAIDs, and should be stopped 2 weeks before eye or other surgery. Can lower the seizure threshold and interacts with some antidepressants and anticonvulsants.
  4. Omega-3 Fatty Acids

    Preliminary evidence

    In a 2018 randomized trial, 105 adults with normal eyes took about 1,000 mg EPA plus 500 mg DHA daily or olive oil for 3 months, and eye pressure fell by about 8 percent, roughly 1 mmHg, in the omega-3 group. Population studies link higher fish intake to modestly lower glaucoma risk, though people who eat more fish differ in many ways. The effect is a fraction of what a single prostaglandin drop achieves and has not been confirmed in people who already have glaucoma.

    Studied dose
    1,000 mg EPA plus 500 mg DHA daily from fish or algal oil, with food.
    Cautions
    Mild blood-thinning effect at higher doses, so tell your surgeon before glaucoma surgery and use caution with anticoagulants. Can cause reflux and loose stools; choose a third-party tested product to limit oxidation.

What matters day to day

  • After each drop, close the eye and press gently on the inner corner by the nose for 1 to 2 minutes: punctal occlusion keeps more drug in the eye and less in the bloodstream, which reduces the fatigue and breathlessness some people get from timolol.
  • Walk briskly or do other moderate aerobic exercise 30 minutes most days: pressure drops by a few mmHg for an hour or two after exercise, and active adults have a lower rate of glaucoma; avoid breath-holding heavy lifts and head-down yoga poses, since a headstand roughly doubles eye pressure within minutes.
  • Sleep with the head of the bed raised about 20 degrees: nighttime eye pressure is the highest of the day, and a wedge pillow lowered it by about 1.5 mmHg in a study of glaucoma patients.
  • Spread your fluids through the day: drinking a quart of water in 5 minutes raises eye pressure by 3 to 4 mmHg for up to an hour, and keep caffeine to a cup or two, especially if glaucoma runs in your family.
  • Loosen your collar: a tight necktie raised eye pressure by about 2 mmHg in most men tested, enough to distort readings at the clinic and, worn all day, enough to matter.
  • Tell your siblings and adult children to get a dilated exam: first-degree relatives have several times the risk, and the exam is covered as a baseline at 40, or earlier with African ancestry, diabetes or high nearsightedness.

Prevention

  • Get comprehensive dilated eye exams regularly, especially after age 40
  • Know your family history of glaucoma
  • Exercise regularly to help lower intraocular pressure
  • Use prescribed eye drops consistently if you have ocular hypertension

When to See a Doctor

  • You experience sudden severe eye pain, headache, or blurred vision
  • You notice halos around lights or sudden vision changes
  • You have risk factors and have not had a recent eye exam
  • Your peripheral vision seems to be narrowing

Frequently Asked Questions

References

  1. Kass MA, Heuer DK, Higginbotham EJ, et al.. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Archives of Ophthalmology (2002)
  2. Heijl A, Leske MC, Bengtsson B, et al.. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Archives of Ophthalmology (2002)
  3. Gazzard G, Konstantakopoulou E, Garway-Heath D, et al.. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet (2019)
  4. Gazzard G, Konstantakopoulou E, Garway-Heath D, et al.. Laser in Glaucoma and Ocular Hypertension (LiGHT) trial: six-year results of primary selective laser trabeculoplasty versus eye drops for the treatment of glaucoma and ocular hypertension. Ophthalmology (2023)
  5. Gedde SJ, Vinod K, Wright MM, et al.; American Academy of Ophthalmology. Primary Open-Angle Glaucoma Preferred Practice Pattern. Ophthalmology (2021)
  6. National Institute for Health and Care Excellence. Glaucoma: diagnosis and management (NICE guideline NG81) (2022)
  7. Hui F, Tang J, Williams PA, et al.. Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: a crossover randomized clinical trial. Clinical and Experimental Ophthalmology (2020)
  8. Kim J, Aschard H, Kang JH, et al.. Intraocular pressure, glaucoma, and dietary caffeine consumption: a gene-diet interaction study from the UK Biobank. Ophthalmology (2021)
  9. Downie LE, Vingrys AJ. Oral omega-3 supplementation lowers intraocular pressure in normotensive adults. Translational Vision Science and Technology (2018)
  10. National Eye Institute. Glaucoma (2024)View source
  11. MedlinePlus, National Library of Medicine. Glaucoma (2024)View source

Related Conditions

Have questions about Glaucoma?

Ask Mother Nature AI for personalized, evidence-based guidance.

Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.